Integrative Care for Type 2 Diabetes

NCT ID: NCT02843724

Last Updated: 2016-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

148 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2019-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A two year, two arm pragmatic trial to investigate the integration of naturopathic care with conventional medical care to provide additional benefit beyond that of conventional medical care alone in achieving adequate control of diabetes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control (Conventional) Arm

Treatment of Type 2 Diabetes according to the Canadian Diabetes Association guidelines. Participants' other health concerns to be addressed as per usual care by practitioners at Wise-Elephant Family Health Team.

Group Type ACTIVE_COMPARATOR

Usual (Conventional) Care

Intervention Type OTHER

2016 Canadian Diabetes Clinical Practice Guidelines (self-management, blood-glucose-lowering, vascular protection, pharmacotherapy) will be implemented

Integrative (Naturopathic + Conventional) Arm

In addition to conventional care, participants will receive free naturopathic care at Brampton Naturopathic Teaching Clinic (located within the Brampton Civic Hospital). Senior student clinicians will provide care under the direct supervision of licensed naturopathic doctors. A naturopathic menu of treatment options have been designed to reflect naturopathic practice and vetted by 3 licensed naturopathic doctors and experts in the field. Participants' other health concerns will be addressed as per naturopathic doctors' discretion.

Group Type ACTIVE_COMPARATOR

Naturopathic Care

Intervention Type OTHER

Naturopathic diabetes care will be selected from a pre-approved menu. Participants' other health concerns will be addressed at naturopathic doctors' discretion

Usual (Conventional) Care

Intervention Type OTHER

2016 Canadian Diabetes Clinical Practice Guidelines (self-management, blood-glucose-lowering, vascular protection, pharmacotherapy) will be implemented

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Naturopathic Care

Naturopathic diabetes care will be selected from a pre-approved menu. Participants' other health concerns will be addressed at naturopathic doctors' discretion

Intervention Type OTHER

Usual (Conventional) Care

2016 Canadian Diabetes Clinical Practice Guidelines (self-management, blood-glucose-lowering, vascular protection, pharmacotherapy) will be implemented

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males or females, enrolled as a patient with WE-FHT
* Ages 21-75 years old
* Diagnosed with type 2 diabetes and not adequately controlled (HbA1c \> 7.0mmol/L)
* Currently seeking care with a medical doctor, nurse practitioner and/or physician assistant
* Willingness to adhere to randomized treatment with availability for follow-up
* Ability to answer self- and interviewer- administered questions in English or have an English speaking caregiver who can aid in answering self- and interviewer- administered questions
* Ability to provide written informed consent or give informed consent through substitute decision maker
* Capacity to maintain a diary and log of treatments and recommendations given during study

Exclusion Criteria

* Lacking capacity for consent
* Pregnancy or an intention to become pregnant in the following two years
* Breastfeeding
* History of myocardial infarction within the past 6 months
* Chronic kidney (eGFR \<30 mL/min) or liver disease
* Actively receiving care from a complex care diabetes clinic
* History of severe hypoglycemia in the last year resulting in hospital emergency care \[where hypoglycemia is defined to be: 1) development of autonomic or neuroglycopenic symptoms, 2) low plasma glucose level (\<4.0mmol/L for patients treated with insulin or an insulin secretagogue) and 3) symptoms responding to the administration of carbohydrate\] or hypoglycemia unawareness
* Current bolus or pre-mixed insulin treatment
* Limited life expectancy (\< 6 months)
* High level of functional dependency (inability to perform common activities of daily living)

1. Recent MI or stroke (within last 6 months)
2. NYHA CHF Functional Capacity Stage III or above
3. NYHA CHF Objective Assessment Stage C or greater (http://www.heart.org/HEARTORG/Conditions/HeartFailure/AboutHeartFailure/Classes-of-Heart-Failure\_UCM\_306328\_Article.jsp)
4. Planned revascularization procedure (PCI or coronary artery bypass graft) or coronary angiogram within 90 days after screening or randomization
Minimum Eligible Age

21 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Canadian College of Naturopathic Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ellen Wong

Co Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ellen Wong, ND

Role: PRINCIPAL_INVESTIGATOR

The Canadian College of Naturopathic Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wise Elephant Family Health Team

Brampton, Ontario, Canada

Site Status

The Canadian College of Naturopathic Medicine

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ellen Wong, ND

Role: CONTACT

416-498-1255 ext. 303

Kieran Cooley, ND

Role: CONTACT

416-498-1255 ext. 324

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sanjeev Goel, MD

Role: primary

(289) 323-0660

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CanadianCNN

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Antioxidant Treatment of Type 2 Diabetes
NCT00609102 COMPLETED EARLY_PHASE1